独占的なCsp(3) -Csp(3) 対 Csp(2) -Csp(3) リデュークティブ・エリミネーションからPt(IV) リガンド制約による
Eric G Bowes1, Shrinwantu Pal1, Jennifer A Love1
1Department of Chemistry, The University of British Columbia , Vancouver, British Columbia V6T 1Z1, Canada.
Journal of the American Chemical Society
|December 18, 2015
まとめ
硬いプラチナ (IV) 複合体からエタンの選択的還元性除去が観察された. この前例のない反応性は,リガンドの硬さが競合する反応のエネルギーバリアを上昇させ,Csp{3}-Csp{3}結合の形成を可能にするためである.
科学分野:
- 有機金属化学
- カタリシス
- 反応メカニズム
背景:
- プラチナ (IV) 複合体は,触媒サイクルにおける多用途の中間物質である.
- 還元性除去 (RE) は多くの触媒変換における重要なステップである.
- 効率的な合成には,還元性排除の選択性を制御することが不可欠です.
研究 の 目的:
- Pt (IV) 複合体からエタン (Csp) 3−Csp (III) RE) の選択的還元性除去のメカニズムを調査する.
- Csp(3) -Csp(3) REとCsp(2) -Csp(3) REの競争に対するリガンド・エスカフォードの硬さの影響を理解する.
- Pt (IV) 化学で前例のない反応性を達成する.
主な方法:
- 異なるリガンドの柔軟性を持つプラチナ (IV) 複合体の合成と特徴付け.
- ブロミド抽出と熱分解を伴う実験研究
- 反応経路とエネルギーバリアを分析するための計算理論研究 (例えば,DFT).
主要な成果:
- 厳格なPt (IV) 複合体からエタンの選択的なCsp (III) -Csp (III) REを観察した.
- リガンド・スキャフォルドの硬さがCsp(2) -Csp(3) REに対するバリアを増やすことが実証された.
- リガンドの硬さの影響による前例のない反応性が確認された.
結論:
- リガンドの設計,特にエスカフォルドの硬さは,Pt ((IV)) 還元性排除における選択性を制御する強力なツールである.
- 固いリガンドは,望ましくないCsp(2) -Csp(3) RE経路を抑制し,Csp(3) -Csp(3) REを好む.
- この研究は,Pt (IV) 中間物質を含む選択的触媒プロセスを開発するための新しい道を開く.
さらに関連する動画
関連する概念動画
Elimination Reactions
18.7K
A nucleophile can react with an alkyl halide to give the substitution product by displacing the halogen. Or it can function as a base to give the elimination product by deprotonation of the neighboring carbon to form an alkene. In an elimination reaction, the substrate loses two groups from adjacent carbons forming at least one π bond. The carbon attached to the halogen is called the α carbon, while the adjacent carbon is called the β carbon; hence, these reactions are called...
18.7K
Radical Formation: Elimination
2.4K
Another method of radical formation is the elimination process. It is the opposite of the addition route and is driven by the instability of the radical. For example, as depicted in Figure 1, dibenzoyl peroxide yields a pair of unstable radicals upon homolysis. Given its instability, this radical spontaneously undergoes elimination via a C–C bond cleavage to form a relatively more stable phenyl radical. The mechanism involves cleavage of the bond between the α and β positions with respect...
2.4K
Phase I Reactions: Reductive Reactions
724
Phase I biotransformation reductive reactions are chemical processes that modify drugs by introducing or revealing polar functional groups via reduction. Enzymes called reductases catalyze these reactions, playing a pivotal role in drug metabolism by transforming lipophilic drugs into more polar, water-soluble metabolites for easy excretion. An essential type of reductive reaction is the carbonyl group reduction, where aldehydes and ketones are reduced to alcohols. An example is the...
724
Woodward–Hoffmann Selection Rules and Microscopic Reversibility
4.2K
Electrocyclic reactions, cycloadditions, and sigmatropic rearrangements are concerted pericyclic reactions that proceed via a cyclic transition state. These reactions are stereospecific and regioselective. The stereochemistry of the products depends on the symmetry characteristics of the interacting orbitals and the reaction conditions. Accordingly, pericyclic reactions are classified as either symmetry-allowed or symmetry-forbidden. Woodward and Hoffmann presented the selection criteria for...
4.2K
Ligand Binding Sites
15.7K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.7K
Ligand Binding Sites
9.1K
9.1K


